Suppressing Src-Mediated EGFR Signaling by Sustained Calcium Supply Targeting Triple-Negative Breast Cancer

Area of Science:

• Oncology
• Molecular Biology
• Biochemistry

Background:

• Src kinase is a promising therapeutic target in triple-negative breast cancer (TNBC).
• Src activation is linked to epidermal growth factor receptor (EGFR) signaling, promoting cancer cell survival.
• Understanding mechanisms of Src regulation is crucial for developing novel TNBC treatments.

Purpose of the Study:

• To investigate the effect of calcium supply on Src degradation in TNBC.
• To elucidate the underlying molecular mechanisms of calcium-mediated Src inhibition.
• To evaluate the anticancer effects of calcium supplementation in a TNBC model.

Main Methods:

• Utilized MDA-MB-231 TNBC cell line and a xenograft animal model.
• Administered calcium via lactate calcium salt (CaLac) to determine optimal concentrations.
• Analyzed signaling molecule expression (Src, EGFR, RAS, ERK, NF-κB, COX-2) using Western blot and immunocytochemistry.
• Assessed effects on prostaglandin E2 receptor signaling.

Main Results:

• Calcium supply significantly suppressed Src expression in TNBC cells.
• This led to decreased expression of downstream signaling molecules including EGFR, RAS, ERK, and NF-κB.
• Suppression of cyclooxygenase-2 (COX-2) resulted in deactivation of prostaglandin E2 receptors.
• Calcium treatment demonstrated anticancer effects in a TNBC xenograft model.

Conclusions:

• Calcium supply effectively induces Src degradation, impacting multiple pro-survival pathways in TNBC.
• This study suggests calcium supplementation as a potential therapeutic strategy for TNBC.
• Further research is required to determine the clinical applicability of calcium for TNBC treatment.